Teva Pharmaceutical Industries (Product Portfolio) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Teva Pharmaceutical Industries (Product Portfolio) General Information
Description
Portfolio of five Abbreviated New Drug Applications in the United States. The asset has five products along with Propofol Injectable Emulsion that has a sales of $340 million on a trailing twelve month basis, per IMS Health.
Contact Information
Corporate Office
- 5 Basel Street
- PO Box 3190
- Petah Tikva
- Israel
Corporate Office
- 5 Basel Street
- PO Box 3190
- Petah Tikva
- Israel
Teva Pharmaceutical Industries (Product Portfolio) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Teva Pharmaceutical Industries (Product Portfolio) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Teva Pharmaceutical Industries (Product Portfolio) FAQs
-
Where is Teva Pharmaceutical Industries (Product Portfolio) headquartered?
Teva Pharmaceutical Industries (Product Portfolio) is headquartered in Petah Tikva, Israel.
-
What industry is Teva Pharmaceutical Industries (Product Portfolio) in?
Teva Pharmaceutical Industries (Product Portfolio)’s primary industry is Buildings and Property.
-
Is Teva Pharmaceutical Industries (Product Portfolio) a private or public company?
Teva Pharmaceutical Industries (Product Portfolio) is a Private company.
-
What is the current valuation of Teva Pharmaceutical Industries (Product Portfolio)?
The current valuation of Teva Pharmaceutical Industries (Product Portfolio) is .
-
What is Teva Pharmaceutical Industries (Product Portfolio)’s current revenue?
The current revenue for Teva Pharmaceutical Industries (Product Portfolio) is .
-
Who are Teva Pharmaceutical Industries (Product Portfolio)’s investors?
Teva Pharmaceutical Industries has invested in Teva Pharmaceutical Industries (Product Portfolio).
-
When was Teva Pharmaceutical Industries (Product Portfolio) acquired?
Teva Pharmaceutical Industries (Product Portfolio) was acquired on 16-Jun-2016.
-
Who acquired Teva Pharmaceutical Industries (Product Portfolio)?
Teva Pharmaceutical Industries (Product Portfolio) was acquired by Sagent Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process